Lisa Marr wanted to know more about the 2-year-old Australian cattle dog she had adopted in Missouri. So like a growing number of dog owners, the Ohio college professor bought a kit to test his DNA.

In February, she took a saliva sample from Badge and mailed it to Embark Veterinary, a Boston startup. A few weeks later, she learned that he is indeed a purebred. But Embark also sent her an email containing what it said “could be alarming news.”

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy